Characterization of the transcriptome profiles related to globin gene switching during in vitro erythroid maturation

Abstract

BackgroundThe fetal and adult globin genes in the human β-globin cluster on chromosome 11 are sequentially expressed to achieve normal hemoglobin switching during human development. The pharmacological induction of fetal γ-globin (HBG) to replace abnormal adult sickle βS-globin is a successful strategy to treat sickle cell disease; however the molecular mechanism of γ-gene silencing after birth is not fully understood. Therefore, we performed global gene expression profiling using primary erythroid progenitors grown from human peripheral blood mononuclear cells to characterize gene expression patterns during the γ-globin to β-globin (γ/β) switch observed throughout in vitro erythroid differentiation.ResultsWe confirmed erythroid maturation in our culture system using cell morphologic features defined by Giemsa staining and the γ/β-globin switch by reverse transcription-quantitative PCR (RT-qPCR) analysis. We observed maximal γ-globin expression at day 7 with a switch to a predominance of β-globin expression by day 28 and the γ/β-globin switch occurred around day 21. Expression patterns for transcription factors including GATA1, GATA2, KLF1 and NFE2 confirmed our system produced the expected pattern of expression based on the known function of these factors in globin gene regulation. Subsequent gene expression profiling was performed with RNA isolated from progenitors harvested at day 7, 14, 21, and 28 in culture. Three major gene profiles were generated by Principal Component Analysis (PCA). For profile-1 genes, where expression decreased from day 7 to day 28, we identified 2,102 genes down-regulated > 1.5-fold. Ingenuity pathway analysis (IPA) for profile-1 genes demonstrated involvement of the Cdc42, phospholipase C, NF-Kβ, Interleukin-4, and p38 mitogen activated protein kinase (MAPK) signaling pathways. Transcription factors known to be involved in γ-and β-globin regulation were identified.The same approach was used to generate profile-2 genes where expression was up-regulated over 28 days in culture. IPA for the 2,437 genes with > 1.5-fold induction identified the mitotic roles of polo-like kinase, aryl hydrocarbon receptor, cell cycle control, and ATM (Ataxia Telangiectasia Mutated Protein) signaling pathways; transcription factors identified included KLF1, GATA1 and NFE2 among others. Finally, profile-3 was generated from 1,579 genes with maximal expression at day 21, around the time of the γ/β-globin switch. IPA identified associations with cell cycle control, ATM, and aryl hydrocarbon receptor signaling pathways.ConclusionsThe transcriptome analysis completed with erythroid progenitors grown in vitro identified groups of genes with distinct expression profiles, which function in metabolic pathways associated with cell survival, hematopoiesis, blood cells activation, and inflammatory responses. This study represents the first report of a transcriptome analysis in human primary erythroid progenitors to identify transcription factors involved in hemoglobin switching. Our results also demonstrate that the in...

Toxic responses in rat embryonic cells to silver nanoparticles and released silver ions as analyzed via gene expression profiles and transmission electron microscopy

“…The globin family is known to play an important role in oxygen transport. Down-regulation of these genes may interfere with either erythropoiesis (which involves actively dividing hematopoietic cells), or heme biosynthesis (which is required for normal hemoglobin production; Li et al, 2012). Blockage of oxygen transport could potentially play an important role in silver ioninduced toxicity.…”

EKLF/KLF1, a Tissue-Restricted Integrator of Transcriptional Control, Chromatin Remodeling, and Lineage Determination

“…Expression of KLF1 mRNA in the adult mouse is restricted to the bone marrow and the red pulp of the spleen (3, 100). KLF1 transcript levels dramatically increase during hematopoietic differentiation, both in vivo and in cell culture assays (101)(102)(103). This is also reflected in the dynamic changes in histone marks (particularly H3K4/K9/ K27/K36 and H4K20) and H2A.Z and RNA Pol II occupancy (101).…”

The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells

“…Its onset in the yolk sac is strictly limited to the mesodermal, primitive erythroid cells that populate the blood islands at the early headfold stage (embryonic day 7.5 [E7.5]), switching by E9.5 to definitive cells within the hepatic primordia and then to the red pulp of the adult spleen and the bone marrow (6). During definitive hematopoietic differentiation, EKLF is expressed at low levels in multipotent progenitors (MPP) and retains an expression pattern restricted to the common myeloid progenitor (CMP) and megakaryocyte erythroid progenitor (MEP) prior to eventual segregation to erythroid progeny (7)(8)(9).…”